Developer docs
API playgroundTry for free, no card

Search company profiles

Virtue

Full company profile

uuid000059v

Namestring
Virtue
Legal namestring
Virtue
Websiteurl
virtuevc.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Virtue is the earliest-stage dedicated healthcare venture capital firm, founded in 2024 and headquartered in Austin, Texas. The firm backs elite founders building AI-native companies that transform the healthcare ecosystem, deploying initial checks of $500K to $4M at the pre-seed and seed stages (the 0-to-1 phase of company building). Its portfolio of 25+ companies spans a deliberately diversified healthcare AI stack, including clinical documentation (Dart Health), healthcare financial planning and FP&A (Translucent), AI-native health insurance brokerage (Gyde), AI-powered dental claims administration (LightSpun), life sciences drug diligence (Prudentia Sciences), multimodal foundation models for biopharma (Standard Model Bio), value-based mental health care (Amae Health), autism care (Anna), senior home care payroll (Clara), clinical trial financial infrastructure (Mural Health), healthcare data compliance (Integral), and precision microbiome care (Evvy).

Virtue's core capability is deal sourcing and thesis-driven investing rather than technology development; the firm itself does not build proprietary AI models, platforms, or software. Its competitive positioning rests on (1) exclusive vertical focus on healthcare AI and life sciences, (2) operational domain expertise brought by its two named principals (Sean Doolan and Emre Karatas, both listed as Investors), and (3) co-investment validation from tier-1 healthcare and tech VCs including GV, NEA, Lightspeed, McKesson Ventures, Optum Ventures, SignalFire, and FPV Ventures across its portfolio rounds.

The business model is conventional venture capital: Virtue raises capital from limited partners, deploys it into portfolio companies in exchange for equity, and earns returns through exits (acquisitions or IPOs). No management fees, AUM, fund size, or realizations are disclosed in the source material. The firm's go-to-market is founder-network-driven direct investment, supplemented by a content-marketing layer of public investment thesis articles published on its website. Geographic focus is the United States, though portfolio companies such as Prudentia Sciences are already expanding into Asia-Pacific and Europe, signaling potential for cross-border deal flow in future funds.

Short descriptiontext

Virtue is a 2024-founded Austin-based venture capital firm that deploys $500K–$4M pre-seed and seed checks into elite founders building AI-native healthcare and life sciences companies. Its 25+ company portfolio spans clinical, financial, insurance, and biopharma AI applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
healthcare venture capital, seed stage investing, healthcare AI startups, early-stage funding, pre-seed investments
Industry2 codes
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
SECONDARYFSANAAAI
Micro-VC & Angel Funds
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Healthcare Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns
TypeLicensing Royalties
Description

Virtue generates returns through equity investments in early-stage healthcare companies. The firm earns returns when portfolio companies achieve successful exits through acquisitions or IPOs.

virtuevc.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Virtue is a venture capital firm that invests in pre-seed and seed stage healthcare AI startups, typically deploying between $500K and $4M per company. The firm backs a portfolio of more than 25 healthcare AI companies and operates from Austin, United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Portfolio company Translucent raised $34M total funding ($7M seed + $27M Series A) and serves hundreds of millions in revenue for customers.
+2 more records
Product overview1 text field

Virtue is a venture capital firm specializing in early-stage healthcare investments, typically deploying $500K to $4M in initial checks to back elite founders transforming the healthcare ecosystem. The firm does not offer a unified product platform; instead, it provides investment capital, strategic guidance, and operational support to early-stage healthcare companies. Its portfolio spans AI-powered healthcare solutions including clinical documentation, financial intelligence, data compliance, and healthcare administration tools.

Product and service1 record
1Pre-seed investment capital
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused venture capital firm investing at seed and early stages in healthcare technology and services companies. Directly comparable to Virtue due to identical healthcare vertical focus and similar early-stage check size thesis.

TypeDirect peer
Description

Seed and early-stage venture firm focused on transformative technology companies. Directly comparable as a micro-VC co-investor, having participated alongside Virtue in Translucent's Series A.

TypeBroad incumbent
Description

The corporate venture arm of Optum/UnitedHealth Group, investing in healthcare AI and technology startups. Comparable as a healthcare-focused VC investor that co-invested with Virtue in Gyde, but operates at meaningfully larger scale.

TypeDirect peer
Description

Early-stage venture capital firm with a dedicated healthcare and AI practice, using proprietary data to source deals. Comparable as an early-stage investor that co-invested with Virtue in Prudentia Sciences.

TypeBroad incumbent
Description

The venture investment arm of Alphabet, making sizable early- and growth-stage bets in healthcare AI and life sciences. Comparable as a co-investor with Virtue in Translucent and Prudentia Sciences, though operating at vastly larger fund scale.

TypeBroad incumbent
Description

Large multi-stage venture firm with deep healthcare and enterprise software coverage. Comparable as a co-investor with Virtue in Gyde's $60M launch, though at materially larger AUM and broader sector focus.

TypeBroad incumbent
Description

Healthcare-focused corporate venture arm of McKesson, investing in startups modernizing pharma, life sciences, and care delivery. Comparable as a healthcare vertical specialist that co-led Prudentia Sciences, but operating at much larger AUM.

TypeDirect peer
Description

Early-stage venture firm investing in healthcare and technology companies, often leading seed and Series A rounds. Comparable as a co-investor with Virtue in LightSpun, with similar healthcare-oriented early-stage thesis.

TypeDirect peer
Description

Early-stage venture firm with deep healthcare, biotech, and frontier-tech specialization, often investing at the earliest stages. Comparable as an early-stage specialist with a strong healthcare thesis, though Lux operates at a larger fund scale and broader sector remit.

TypeBroad incumbent
Description

Andreessen Horowitz's dedicated bio/healthcare investment fund, investing across stages in healthcare AI, biotech, and digital health. Comparable as a high-profile healthcare AI investor, though operating at vastly larger AUM and broader stage range than Virtue.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment24 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Virtue

Healthcare Venture Capitalvirtuevc.com

Virtue is a 2024-founded Austin-based venture capital firm that deploys $500K–$4M pre-seed and seed checks into elite founders building AI-native healthcare and life sciences companies. Its 25+ company portfolio spans clinical, financial, insurance, and biopharma AI applications.

What Virtue does

Virtue is the earliest-stage dedicated healthcare venture capital firm, founded in 2024 and headquartered in Austin, Texas. The firm backs elite founders building AI-native companies that transform the healthcare ecosystem, deploying initial checks of $500K to $4M at the pre-seed and seed stages (the 0-to-1 phase of company building). Its portfolio of 25+ companies spans a deliberately diversified healthcare AI stack, including clinical documentation (Dart Health), healthcare financial planning and FP&A (Translucent), AI-native health insurance brokerage (Gyde), AI-powered dental claims administration (LightSpun), life sciences drug diligence (Prudentia Sciences), multimodal foundation models for biopharma (Standard Model Bio), value-based mental health care (Amae Health), autism care (Anna), senior home care payroll (Clara), clinical trial financial infrastructure (Mural Health), healthcare data compliance (Integral), and precision microbiome care (Evvy).

Virtue's core capability is deal sourcing and thesis-driven investing rather than technology development; the firm itself does not build proprietary AI models, platforms, or software. Its competitive positioning rests on (1) exclusive vertical focus on healthcare AI and life sciences, (2) operational domain expertise brought by its two named principals (Sean Doolan and Emre Karatas, both listed as Investors), and (3) co-investment validation from tier-1 healthcare and tech VCs including GV, NEA, Lightspeed, McKesson Ventures, Optum Ventures, SignalFire, and FPV Ventures across its portfolio rounds.

The business model is conventional venture capital: Virtue raises capital from limited partners, deploys it into portfolio companies in exchange for equity, and earns returns through exits (acquisitions or IPOs). No management fees, AUM, fund size, or realizations are disclosed in the source material. The firm's go-to-market is founder-network-driven direct investment, supplemented by a content-marketing layer of public investment thesis articles published on its website. Geographic focus is the United States, though portfolio companies such as Prudentia Sciences are already expanding into Asia-Pacific and Europe, signaling potential for cross-border deal flow in future funds.

Virtue firmographics

Firmographics
Name
Virtue
Legal name
Virtue
Website
https://virtuevc.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Virtue is a 2024-founded Austin-based venture capital firm that deploys $500K–$4M pre-seed and seed checks into elite founders building AI-native healthcare and life sciences companies. Its 25+ company portfolio spans clinical, financial, insurance, and biopharma AI applications.
Ownership category
akta.pro rank

Virtue industry classification

Industry
Product category
Healthcare Venture Capital
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Security Brokers, Dealers & Flotation Companies (6211)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
SECONDARYFSANAAAI
Micro-VC & Angel Funds

Keywords

  • Healthcare venture capital
  • Seed stage investing
  • Healthcare AI startups
  • Early-stage funding
  • Pre-seed investments

Where Virtue is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Markets served

Virtue business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Venture Capital Returns: Virtue generates returns through equity investments in early-stage healthcare companies. The firm earns returns when portfolio companies achieve successful exits through acquisitions or IPOs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Virtue product offering

Product offering

Core offering

Virtue is a venture capital firm that invests in pre-seed and seed stage healthcare AI startups, typically deploying between $500K and $4M per company. The firm backs a portfolio of more than 25 healthcare AI companies and operates from Austin, United States.

Product overview

Virtue is a venture capital firm specializing in early-stage healthcare investments, typically deploying $500K to $4M in initial checks to back elite founders transforming the healthcare ecosystem. The firm does not offer a unified product platform; instead, it provides investment capital, strategic guidance, and operational support to early-stage healthcare companies. Its portfolio spans AI-powered healthcare solutions including clinical documentation, financial intelligence, data compliance, and healthcare administration tools.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pre-seed investment capital

Quantifiable outcome

  • Portfolio company Translucent raised $34M total funding ($7M seed + $27M Series A) and serves hundreds of millions in revenue for customers.
  • +2 more outcomes

Companies that use Virtue

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Virtue technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Virtue partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Virtue competitors and assessment

Company assessment

Direct peers

  • Flare Capital Partners: Healthcare-focused venture capital firm investing at seed and early stages in healthcare technology and services companies. Directly comparable to Virtue due to identical healthcare vertical focus and similar early-stage check size thesis.
  • FPV Ventures: Seed and early-stage venture firm focused on transformative technology companies. Directly comparable as a micro-VC co-investor, having participated alongside Virtue in Translucent's Series A.
  • SignalFire: Early-stage venture capital firm with a dedicated healthcare and AI practice, using proprietary data to source deals. Comparable as an early-stage investor that co-invested with Virtue in Prudentia Sciences.
  • Brewer Lane Ventures: Early-stage venture firm investing in healthcare and technology companies, often leading seed and Series A rounds. Comparable as a co-investor with Virtue in LightSpun, with similar healthcare-oriented early-stage thesis.
  • Lux Capital: Early-stage venture firm with deep healthcare, biotech, and frontier-tech specialization, often investing at the earliest stages. Comparable as an early-stage specialist with a strong healthcare thesis, though Lux operates at a larger fund scale and broader sector remit.

Broad incumbents

  • Optum Ventures: The corporate venture arm of Optum/UnitedHealth Group, investing in healthcare AI and technology startups. Comparable as a healthcare-focused VC investor that co-invested with Virtue in Gyde, but operates at meaningfully larger scale.
  • GV (Google Ventures): The venture investment arm of Alphabet, making sizable early- and growth-stage bets in healthcare AI and life sciences. Comparable as a co-investor with Virtue in Translucent and Prudentia Sciences, though operating at vastly larger fund scale.
  • Lightspeed Venture Partners: Large multi-stage venture firm with deep healthcare and enterprise software coverage. Comparable as a co-investor with Virtue in Gyde's $60M launch, though at materially larger AUM and broader sector focus.
  • McKesson Ventures: Healthcare-focused corporate venture arm of McKesson, investing in startups modernizing pharma, life sciences, and care delivery. Comparable as a healthcare vertical specialist that co-led Prudentia Sciences, but operating at much larger AUM.
  • a16z Bio + Health: Andreessen Horowitz's dedicated bio/healthcare investment fund, investing across stages in healthcare AI, biotech, and digital health. Comparable as a high-profile healthcare AI investor, though operating at vastly larger AUM and broader stage range than Virtue.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Virtue social profiles

Digital presence

Virtue financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Virtue leadership team

Management profile

Number of profiles

Profiles2 records

Virtue funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Virtue M&A and investment

M&A and investment

M&A

Investments24 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virtue

What does Virtue do?

Virtue is a venture capital firm that invests in pre-seed and seed stage healthcare AI startups, typically deploying between $500K and $4M per company. The firm backs a portfolio of more than 25 healthcare AI companies and operates from Austin, United States.

Is Virtue a public or private company?

Virtue is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Virtue founded?

Virtue was founded in 2024. It employs 11 to 50 people.

Where is Virtue based?

Virtue is headquartered in Austin, United States, in the North America region.

How does Virtue make money?

One revenue line is on record: venture Capital Returns.

Who are Virtue's main competitors?

Direct peers on record are Flare Capital Partners, FPV Ventures, SignalFire, Brewer Lane Ventures and Lux Capital. Broad incumbents are Optum Ventures, GV (Google Ventures), Lightspeed Venture Partners, McKesson Ventures and a16z Bio + Health.

Does Virtue have an API?

No public API is recorded for Virtue.

What industry is Virtue in?

Virtue's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAAAI, Micro-VC & Angel Funds. Its NAICS code is 523940 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Kanurra Raises $6.35 Million To Build Pharmacy Benefit Manager For Small And Midsize EmployersKanurra, a newly founded pharmacy benefit manager targeting small and midsize employers, has raised $6.35 million in seed funding from multiple venture capital firms including Asylum Ventures, Daybreak Ventures, Virtue VC, Necessary Ventures, Ford Street Ventures, and Browder Capital. The company is building routing and administrative infrastructure to reduce drug costs for employers who face opacity and lack of control over pharmaceutical pricing. Founder Semih Gultekin, who left Aviary Health to start the company, stated the firm already has strong broker and third-party administrator interest with customers ready to onboard.ZawyaUAE’s rising as global startup powerhouse with Abu Dhabi’s Median Series A funding surpasses Tokyo, London and BerlinAbu Dhabi's startup ecosystem is valued at $4.2 billion, a 7.7% year-on-year increase, with median Series A funding at $11 million. This exceeds the global average of $6.8 million and surpasses Tokyo, London, and Berlin. Virtue PR launched a strategic communications offering for UAE startups.NeofeedMerger creates investment advisory firm with R$4.5 billion under custodyNucleopar Investimentos and Virtue completed a merger on March 13th, forming a platform managing R$4.5 billion in assets under custody with approximately 150 advisors and 7,200 active clients. The combined entity, operating under the Nucleopar brand, integrates Nucleopar's R$3 billion equity-focused client base with Virtue's R$1.5 billion fixed income and investor education operations to generate revenue synergies. Veritas served as the sole transaction advisor, with CEO Marcelo Porto stating the firm aims to position itself as a consolidator among mid-sized advisory firms as the Brazilian market shows declining new entrants.Pulse 2.0Translucent: $27 Million Raised For AI Healthcare Finance PlatformTranslucent, an AI platform for healthcare finance, announced it raised $27 million in a Series A funding round led by GV, with continued participation from NEA, Virtue, and FPV Ventures, just months after closing a $7 million seed round in August 2025. The platform consolidates operational, clinical, and financial data to provide real-time financial visibility for healthcare organizations facing margin pressures, with clients including Northwestern Medicine, Duly Health and Care, and rural hospitals. The company plans to use the funding to accelerate product development and expand its team as it works to bring real-time financial intelligence to more health systems across the United States.FortuneExclusive: Translucent, an AI-native healthcare finance startup, raises $27 million Series ATranslucent, an AI-native healthcare finance startup founded in 2024 by former Springfield Clinic chief information officer Jack O'Hara, has raised a $27 million Series A round led by GV with participation from NEA, FPV Ventures, and Virtue. The startup provides hospitals with AI-powered financial monitoring and forecasting tools designed to address the industry\'s challenge of managing fuzzy, delayed billing data in a $5 trillion market operating at roughly 1% margins. Translucent previously raised a $7 million seed round in August, and counts rural health systems like Wray Community District Hospital and Clinic among its customers.KuCoinAI-native healthcare finance startup Translucent completes $27M Series A roundTranslucent, an AI-native healthcare finance startup, has closed a $27 million Series A round led by GV, with participation from NEA, FPV Ventures, and Virtue. The company, which previously raised $7 million in seed funding in August 2024, develops AI-powered financial agents for hospitals that provide real-time data monitoring and decision support. The startup was spun off from Chainthink, an AI and crypto news outlet.AxiosHealth Tech: New startup juiceTuva Health raised a $5 million seed round led by Virtue, with participation from Box Group and Y Combinator. The startup's open-source data-cleaning platform has roughly $1 million in annual run-rate revenue. Tuva aims to reach break-even in the first half of 2025 while expanding partnerships with payers, providers, and pharmaceutical companies.HIT ConsultantIntegral Secures $6.9M to Expand Real-Time Compliance for Life SciencesIntegral raised $6.9M in seed funding led by Haystack, The General Partnership, and Virtue Ventures. The company provides automated de-identification and compliance certification software for health and life sciences data. The funding aims to enable access to compliant, de-identified data in hours rather than months.BioSpaceSynthetica Bio Launches with Venture Funding to Develop a Generative AI Platform Purpose-Built for BiopharmaSynthetica Bio has officially launched its generative AI platform for the biopharma industry, securing seed funding led by Virtue with participation from AIX Ventures and Page One Ventures. The company aims to address data analysis bottlenecks in drug development and commercial targeting by leveraging large language models on de-identified patient data.